The Embassy of France to Japan, Science division

The Office for Science and Technology of the French Embassy to Japan is in charge of promoting scientific and technological partnerships between French and Japanese research stakeholders.

The office assists laboratories, universities, research institutes, funding agencies, companies, competitiveness clusters and all scientific and technological institutions, both in France and in Japan, in initiating or developing their research and technology partnerships between the two countries by:

• Identifying partners in the other country and accompanying them in the first stages of the dialogue;

• Organizing scientific events to bring together actors from both countries;

• Organizing official missions for institutional representatives, research organizations and funding agencies.

The National Cancer Center of Japan (NCC)

Established by the Ministry of Health and Welfare in 1962, the National Cancer Center (NCC) leads the nation’s cancer treatment, prevention, control programs, research, and education.

The leadership participates, and leads expert bodies appointed by the Ministry of Health, Labour and Welfare in the fight against cancer. Expertise is shared with the medical profession globally, with a focus on Asia.

In 2010, it was designated an incorporated administrative agency (autonomous public service body), and then a national research and development agency in 2015, respectively remaining under the auspices of the Ministry of Health, Labour and Welfare.

NCC is committed to providing the best possible cancer treatment and care through relentless partnership with the community.

The National Cancer Center main missions are:

  • Discover the fundamental causes of cancer, towards early diagnosis and prevention;
  • Promote innovation in diagnosis and treatment;
  • Establish and make available the most advanced standard of care to all patients;
  • Explore and support patients with the best “cancer survivorship”;
  • Gather cancer information and disseminate to society;
  • Develop talent;
  • Advocate policies;
  • Contribute globally, working with international partners.

The French National Cancer Institute (INCa)

The French National Cancer Institute (INCa) was established under the French Public Health Act of August 9, 2004, as the State health and science agency specialised in cancer control.

INCa is a Public Interest Group (GIP) and operates under the dual supervision of the French Ministry of Health and Solidarities and the French Ministry of Higher Education, Research and Innovation.

The Institute provides an integrated approach encompassing all cancer-control aspects (health, scientific, social and economic) and intervention areas (prevention, screening, care and research) to catalyse progress and, thus, to benefit patients and their relatives.

Main French cancer research funder, INCa’s strategic goals in research and promoting access to innovation are:
  • To propose adapted programmes for cancer research projects funding and cancer research structuring to support emerging and strategic research fields (biology, translational, clinical and human and social sciences-epidemiology-public health);
  • To spur translation of fundamental discoveries into policy and practices for the patients’ benefit;
  • To increase biological and clinical resources for researchers;
  • To promote clinical research, particularly, new molecular-driven trials tailored to targeted therapies and more broadly to innovations in drugs or technologies;
  • To ensure that research drives improvements;
  • To enhance training in cancer research.

Through its missions in leading and coordinating the cancer research actions and the stakeholders, INCa aims to accelerate the innovation transfer for patients benefit.